Narrowing Breast Cancer Disparities Through Collaborative Research and Trial Representation
Dr. Patricia A. Robinson discusses strategies to reduce racial disparities in breast cancer outcomes, focusing on clinical trial representation and the impact of metabolic syndrome. The discussion emphasizes collaboration between academic centers and community oncologists to improve equitable care.
Why it matters
Addressing health disparities is critical for improving survival rates and ensuring equitable medical outcomes across diverse patient populations.
Although gains have been made across the cancer control continuum, racial disparities in breast cancer outcomes remain well documented, prompting renewed focus on their underlying drivers and on how research is designed and conducted.
CancerNetwork® spoke with Patricia A. Robinson, MD, associate professor of medicine in the Division of Hematology and Oncology at Northwestern University Feinberg School of Medicine and associate director for diversity, equity, and inclusion at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, about efforts to address disparities in breast cancer care.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in